USPTO serial 79321619
COAPTIUM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 25, 2023
- Examiner
- RENNIE, GABRIELLE M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with COAPTIUM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Pradeep Jayaraman
Pradeep Jayaraman IpHorgan Ltd.195 Arlington Heights RoadSuite 125Buffalo Grove, IL 60089Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical, surgical, and veterinary preparations for repairing nerves, for cardiovascular treatment; chemical preparations for medical, surgical, pharmaceutical or veterinary use for nerve repair, and cardiovascular treatment; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets, and pharmaceutical preparations for nerve repair and cardiovascular treatment; capsules made of dendrimer-based polymers sold empty for pharmaceuticals, pharmaceutical preparations, namely, a drug delivery system comprising polymer based-oral tablets for the continuous release of a wide variety of therapeutic agents for medical, surgical, pharmaceutical, or veterinary use for nerve repair and cardiovascular treatment; adhesive, namely, glues and sealants for medical, surgical, pharmaceutical, or veterinary use for nerve repair and cardiovascular treatment; biological or chemical preparations for medical, surgical, pharmaceutical or veterinary use for nerve repair and cardiovascular treatment; diagnostic products, namely, medical diagnostic test media in the form of strips and medical preparations for medical use for nerve repair and cardiovascular treatment | ACTIVE | — |
| 010 | Medical, surgical and veterinary apparatus and instruments for nerve repair and cardiovascular treatment; medical devices for nerve repair and cardiovascular treatment, namely, device for improving nerve regeneration and repair, for reconnecting and protecting nerves; artificial hip, breast, larynx, and hand implants, joint, hip, breath, dental, bone prostheses, and artificial vascular grafts, connectors, joints, and substitutes for tendons; suture, fastening, artificial repair, and protection material for implants, prostheses, grafts, and tendons; syringes for medical or surgical use and applicators in the nature of syringe barrels for syringes for medical or surgical applications; surgical lamps; medical examination lamps; heating lamps for medical applications | ACTIVE | — |
| 042 | Biological and biochemical research services in the field of nerve repair and cardiovascular applications; scientific and technological research and development services, namely, chemical and medical chemistry research in the field of nerve repair and cardiovascular applications; research and development services for pharmaceutical products in the field of nerve repair and cardiovascular applications; medical research and clinical studies in the field of nerve repair and cardiovascular applications; quality control services for preparations and products for medical use for nerve repair and cardiovascular applications | ACTIVE | — |
| 044 | Medical services in the field of nerve repair and cardiovascular applications; providing medical information in the field of nerve repair and cardiovascular applications treatment | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TISSIUM
- Other trademarks owned by TISSIUM
- Other trademarks owned by TISSIUM
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named COAPTIUM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 20, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 2, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 2, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 25, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 25, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 25, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 20, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 1, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 1, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 7, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 7, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 7, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 18, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 18, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 18, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 4, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 1, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 30, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 30, 2022 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Sep 14, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 14, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 14, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 25, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 22, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 22, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 22, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 11, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 21, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 21, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 18, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 17, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 10, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 12, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 7, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 30, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |